LifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Rating of “Moderate Buy” by Brokerages

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, five have given a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $9.00.

Several equities analysts recently commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday, December 29th. Wall Street Zen upgraded shares of LifeStance Health Group from a “hold” rating to a “buy” rating in a report on Sunday, February 8th. Barclays started coverage on shares of LifeStance Health Group in a research report on Tuesday, December 9th. They set an “overweight” rating and a $8.00 price objective for the company. UBS Group lifted their target price on LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, November 7th. Finally, BMO Capital Markets began coverage on LifeStance Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $8.00 price target on the stock.

LifeStance Health Group Stock Down 0.6%

Shares of LFST stock opened at $7.15 on Friday. LifeStance Health Group has a 12 month low of $3.74 and a 12 month high of $8.30. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.18. The firm has a market cap of $2.78 billion, a PE ratio of -238.33 and a beta of 1.12. The stock has a 50 day moving average of $7.11 and a 200-day moving average of $6.11.

Insiders Place Their Bets

In related news, insider Ann Varanakis sold 50,000 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $6.90, for a total value of $345,000.00. Following the completion of the transaction, the insider directly owned 315,610 shares of the company’s stock, valued at $2,177,709. This trade represents a 13.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert Bessler sold 119,942 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $7.04, for a total transaction of $844,391.68. Following the completion of the sale, the director directly owned 1,318,983 shares in the company, valued at $9,285,640.32. This trade represents a 8.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 270,086 shares of company stock valued at $1,891,264 over the last 90 days. 3.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On LifeStance Health Group

Several institutional investors have recently added to or reduced their stakes in the company. Larson Financial Group LLC grew its stake in LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after buying an additional 3,791 shares during the last quarter. Bayesian Capital Management LP acquired a new position in shares of LifeStance Health Group in the 2nd quarter worth approximately $52,000. Krane Funds Advisors LLC bought a new stake in LifeStance Health Group during the 4th quarter worth approximately $71,000. Vanguard Personalized Indexing Management LLC acquired a new stake in LifeStance Health Group during the 3rd quarter valued at $72,000. Finally, Cibc World Markets Corp bought a new position in LifeStance Health Group in the 4th quarter valued at $77,000. 85.50% of the stock is owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.